IRIS
EMDIN, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 81.923
EU - Europa 44.058
AS - Asia 41.927
SA - Sud America 9.289
Continente sconosciuto - Info sul continente non disponibili 1.222
AF - Africa 1.063
OC - Oceania 83
Totale 179.565
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 77.646
SG - Singapore 15.115
RU - Federazione Russa 10.948
CN - Cina 10.432
IT - Italia 9.957
GB - Regno Unito 8.431
BR - Brasile 7.194
VN - Vietnam 6.008
HK - Hong Kong 3.009
DE - Germania 3.008
CA - Canada 2.949
BD - Bangladesh 2.739
UA - Ucraina 2.666
FR - Francia 1.626
DK - Danimarca 1.587
SE - Svezia 1.413
FI - Finlandia 1.102
IN - India 963
MX - Messico 774
IE - Irlanda 763
AR - Argentina 717
PL - Polonia 713
NL - Olanda 557
TR - Turchia 511
ID - Indonesia 436
IL - Israele 410
EC - Ecuador 384
ZA - Sudafrica 368
ES - Italia 356
JP - Giappone 341
IQ - Iraq 339
PK - Pakistan 297
CO - Colombia 262
VE - Venezuela 205
AT - Austria 202
MA - Marocco 173
UZ - Uzbekistan 159
CL - Cile 151
EU - Europa 149
AE - Emirati Arabi Uniti 138
SA - Arabia Saudita 132
LT - Lituania 130
PY - Paraguay 129
MY - Malesia 109
EG - Egitto 103
PE - Perù 98
PH - Filippine 98
CR - Costa Rica 94
JM - Giamaica 92
KE - Kenya 91
TN - Tunisia 84
KR - Corea 76
DZ - Algeria 71
UY - Uruguay 71
JO - Giordania 68
HN - Honduras 64
CH - Svizzera 63
BO - Bolivia 61
BE - Belgio 60
IR - Iran 60
NP - Nepal 55
SK - Slovacchia (Repubblica Slovacca) 55
AU - Australia 53
AZ - Azerbaigian 49
PT - Portogallo 47
RO - Romania 46
GT - Guatemala 44
DO - Repubblica Dominicana 42
AL - Albania 40
KZ - Kazakistan 40
CZ - Repubblica Ceca 39
NI - Nicaragua 37
TW - Taiwan 37
TH - Thailandia 36
TT - Trinidad e Tobago 35
ET - Etiopia 34
OM - Oman 32
SV - El Salvador 30
HU - Ungheria 28
KG - Kirghizistan 27
GR - Grecia 26
PA - Panama 24
AM - Armenia 23
LB - Libano 23
PS - Palestinian Territory 22
RS - Serbia 22
BB - Barbados 21
CI - Costa d'Avorio 21
PR - Porto Rico 21
SN - Senegal 21
GE - Georgia 20
KW - Kuwait 19
NO - Norvegia 19
NZ - Nuova Zelanda 19
SI - Slovenia 18
LV - Lettonia 17
MD - Moldavia 17
QA - Qatar 17
BG - Bulgaria 16
BH - Bahrain 16
Totale 178.160
Salva come PNG Salva come JPEG
Città #
Dallas 13.967
Singapore 7.653
Southend 5.518
Ashburn 5.305
San Jose 5.291
Beijing 4.112
Woodbridge 2.876
Hong Kong 2.735
Chandler 2.556
Ann Arbor 2.548
Houston 2.389
Los Angeles 2.299
Council Bluffs 2.270
Moscow 1.995
Fairfield 1.914
Chicago 1.882
San Mateo 1.857
Ho Chi Minh City 1.732
Milan 1.633
Falls Church 1.553
Seattle 1.357
Dearborn 1.328
New York 1.279
Jacksonville 1.224
The Dalles 1.180
Wilmington 1.171
Cambridge 1.161
Hanoi 1.085
Rome 1.048
Ottawa 957
Santa Clara 947
Buffalo 932
Hefei 806
Lauterbourg 798
São Paulo 790
Salt Lake City 766
Boardman 762
Dublin 741
Portsmouth 685
Stevenage 685
Pisa 663
Warsaw 643
Dong Ket 641
Helsinki 554
Lawrence 526
Brooklyn 473
Beauharnois 444
Orem 438
Tampa 434
Phoenix 422
Munich 412
Montréal 406
Montreal 392
London 375
Elk Grove Village 369
Tel Aviv 354
Mexico City 352
Florence 316
Frankfurt am Main 300
Tokyo 291
Denver 277
Columbus 269
Chennai 268
Toronto 267
Atlanta 255
Rio de Janeiro 253
Johannesburg 234
Stockholm 234
San Diego 232
Istanbul 231
Amsterdam 226
Poplar 221
Figino 219
Da Nang 211
Nuremberg 206
Haiphong 197
Naples 188
Turin 179
Boston 176
Miami 174
Sterling 165
Bologna 163
Redwood City 161
Lancaster 160
Old Bridge 158
Belo Horizonte 146
San Francisco 146
Tashkent 144
Brasília 140
Manchester 136
Lappeenranta 132
Guangzhou 131
Guayaquil 129
Washington 122
Biên Hòa 121
Ankara 120
Curitiba 119
Quito 119
Mumbai 116
Central District 114
Totale 107.851
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.851
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.711
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.585
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology 1.364
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 899
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 743
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 633
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 625
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 520
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 510
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 495
Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study 493
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 470
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 458
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 455
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 432
[18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions 421
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 404
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 403
A simple echocardiographic score to rule out cardiac amyloidosis 396
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 394
Impaired HDL Cholesterol Function and High Interleukin-1ß Levels Hold Prognostic Value after ST-elevation Myocardial Infarctio 392
Trastuzumab cardiotoxicity and drug cardioprotection in healthy and cardiac dysfunction mouse models 387
A simple echocardiographic score to rule out cardiac amyloidosis 382
Cartella clinica automatizzata per il reparto di cardiologia 381
An Open System for Managing Long Term ECG Recordings 378
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 376
Meteorin-like protein is associated with a higher risk profile and predicts a worse outcome in patients with STEMI 374
Intelligent data retrieval system as a decision support in cardiology in an Intranet environment 369
Building medical knowledge from real world registries: The case of heart failure 369
Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: A marker of advanced disease and electrical myocardial instability 363
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 363
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 357
Central sleep apnea and cardiovascular disease state-of-the-art 354
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 353
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 351
[Central apneas and cardiovascular diseases] 346
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 345
La neuropatia diabetica 345
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 345
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 344
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 344
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 343
Prognostic Impact of QRS Axis Deviation in Patients Treated with Cardiac Resynchronization Therapy 339
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 338
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 338
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 337
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 337
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 337
Etiology, clinical presentation, and management of left main coronary artery aneurysms 336
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 336
Prediction of the chemoreflex gain by common clinical variables in heart failure 335
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 334
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 334
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 333
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 332
Treating chemoreflex in heart failure: modulation or demolition? 329
Preliminary usability assessment for a novel robotic interface for remote Doppler-echocardiography 329
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 329
Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis 325
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 323
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 323
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis 323
Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction 321
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 321
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 319
Adrenergic activation in heart failure: blockade or rebalance? 317
Effects of smoking in patients treated with cardiac resynchronization therapy 314
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation 314
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 314
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 313
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy 311
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 311
Aortic elasticity indices by magnetic resonance predict progression of ascending aorta dilation 311
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 310
Eligibility for vericiguat in a real‐world, contemporary heart failure population 310
Biomarcatori di stabilità della placca aterosclerotica (Rassegna) 309
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 309
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 308
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 308
Acute right-sided transcutaneous vagus nerve stimulation improves cardio-vagal baroreflex gain in patients with chronic heart failure 307
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 306
Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure 306
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 306
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias 306
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 305
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 305
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy 305
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis 304
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 304
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 303
[Ten perspectives for research and innovation in cardiac amyloidosis] 302
[Treatment of cardiac fibrosis: from neurohormonal antagonists to CAR-T cells] 301
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 301
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 301
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: A cardiac MR study 301
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 300
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 299
Screening the health status of people working in a university 297
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 297
Totale 41.246
Salva come PNG Salva come JPEG
Categoria #
all - tutte 900.009
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 900.009
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.511 0 0 404 889 180 250 922 1.669 502 941 138 616
2022/20235.887 547 376 172 845 776 931 52 486 1.037 118 330 217
2023/20244.142 345 129 800 249 173 445 352 194 212 202 162 879
2024/202534.849 265 325 1.822 648 1.291 1.781 4.145 7.450 2.628 3.805 6.753 3.936
2025/202686.022 4.277 13.594 10.172 10.737 8.516 5.099 8.838 3.744 5.070 5.490 5.087 5.398
2026/20276.649 2.362 2.871 1.416 0 0 0 0 0 0 0 0 0
Totale 179.565